FSP-1 expression in cancer cells is relevant to long-term oncological outcomes in nonmetastatic colorectal cancer
Sun Bin Im, Jae Min Cho, Han Byul Kim, Dong-Hoon Shin, Myeong Sook Kwon, In Young Lee, Gyung Mo Son
Korean J Clin Oncol. 2022;18(2):66-77. Published online 2022 Dec 30 DOI: https://doi.org/10.14216/kjco.22009
Citations to this article as recorded by 
Nano-drug delivery strategies affecting cancer-associated fibroblasts to reduce tumor metastasis
Linghui Zou, Peng Xian, Qing Pu, Yangjie Song, Shuting Ni, Lei Chen, Kaili Hu
Acta Pharmaceutica Sinica B.2025;[Epub] CrossRef
Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Zhipeng Cao, Sadia Quazi, Sakshi Arora, Laura D. Osellame, Ingrid J. Burvenich, Peter W. Janes, Andrew M. Scott
Journal of Biomedical Science.2025;[Epub] CrossRef
Advances in nanotechnology for targeting cancer-associated fibroblasts: A review of multi-strategy drug delivery and preclinical insights
Zhongsong Zhang, Yujie Tang, Dan Luo, Jing Qiu, Long Chen
APL Bioengineering.2025;[Epub] CrossRef
Targeting ferroptosis regulators by natural products in colorectal cancer
Yiping Zhang, Jun Xie
Frontiers in Pharmacology.2024;[Epub] CrossRef
Unveiling ferroptosis as a promising therapeutic avenue for colorectal cancer and colitis treatment
Aaron T. Kao, Christian V. Cabanlong, Kendra Padilla, Xiang Xue
Acta Pharmaceutica Sinica B.2024; 14(9): 3785. CrossRef
GPX4 and FSP1 Expression in Lung Adenocarcinoma: Prognostic Implications and Ferroptosis-Based Therapeutic Strategies
Hirotomo Takahara, Takumi Kanazawa, Haruna Oshita, Yoshinobu Tomita, Yuri Hananoi, Sachiko Ishibashi, Masumi Ikeda, Asuka Furukawa, Mayumi Kinoshita, Kurara Yamamoto, Yuki Kato, Hironori Ishibashi, Kenichi Okubo, Morito Kurata, Masanobu Kitagawa, Kenichi
Cancers.2024; 16(22): 3888. CrossRef